Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 5,664.72 | 3,624.60 | 4,400.71 | 3,462.88 |
Total Revenue | 5,664.72 | 3,624.60 | 4,400.71 | 3,462.88 |
Costof Revenue Total | 2,173.09 | 1,733.32 | 2,149.33 | 1,538.17 |
Gross Profit | 3,491.63 | 1,891.28 | 2,251.38 | 1,924.70 |
Selling/ General/ Admin Expenses Total | 1,486.88 | 810.00 | 694.61 | 590.16 |
Depreciation/ Amortization | 344.57 | 146.74 | 110.30 | 98.78 |
Unusual Expense( Income) | 0.00 | 62.79 | - | - |
Other Operating Expenses Total | 671.68 | 9.73 | 3.79 | 0.12 |
Total Operating Expense | 4,676.22 | 2,802.95 | 3,000.67 | 2,259.43 |
Operating Income | 988.51 | 821.65 | 1,400.03 | 1,203.45 |
Interest Inc( Exp) Net- Non- Op Total | -262.00 | 2,331.23 | 2,189.37 | 1,235.64 |
Other Net | 170.24 | -0.11 | -0.24 | 7.78 |
Net Income Before Taxes | 1,132.54 | 1,054.58 | 1,618.55 | 1,334.81 |
Provisionfor Income Taxes | 360.08 | 273.54 | 406.89 | 337.85 |
Net Income After Taxes | 772.46 | 781.04 | 1,211.66 | 996.96 |
Net Income Before Extra Items | 772.46 | 781.04 | 1,211.66 | 996.96 |
Net Income | 772.46 | 781.04 | 1,211.66 | 996.96 |
Income Availableto Com Excl Extra Ord | 772.46 | 781.04 | 1,211.66 | 996.96 |
Income Availableto Com Incl Extra Ord | 772.46 | 781.04 | 1,211.66 | 996.96 |
Diluted Net Income | 772.46 | 781.04 | 1,211.66 | 996.96 |
Diluted Weighted Average Shares | 16.47 | 16.47 | 16.45 | 15.83 |
Diluted EPS Excluding Extra Ord Items | 46.89 | 47.43 | 73.64 | 62.99 |
DPS- Common Stock Primary Issue | 20.00 | - | - | - |
Diluted Normalized EPS | 46.89 | 50.26 | 73.65 | 62.99 |
Research Development | - | 403.77 | 426.56 | 321.99 |
Gain( Loss)on Saleof Assets | - | -0.81 | -1.78 | 0.24 |
Gland Pharma Dividend Gland Pharma Bonus Gland Pharma News Gland Pharma AGM Gland Pharma Rights Gland Pharma Splits Gland Pharma Board Meetings Gland Pharma Key Metrics Gland Pharma Shareholdings Gland Pharma Balance Sheet Gland Pharma Cashflow Gland Pharma Q1 Results Gland Pharma Q2 Results Gland Pharma Q3 Results Gland Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks